Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer
Stephen K. Williamson, John Crowley, Robert B. Livingston, Geoffrey WeissVolume:
11
Language:
english
Pages:
3
DOI:
10.1007/bf00873917
Date:
February, 1993
File:
PDF, 201 KB
english, 1993